Development of customized inner beauty products and customized cosmetics apps according to the use of NRF2 through DTC genetic testing after the COVID-19 pandemic.
4th industrial revolution
COVID-19
DTC genetic test
NRF2
antioxidants
customized cosmetics
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
02
04
2022
received:
07
08
2021
accepted:
08
09
2021
pubmed:
26
4
2022
medline:
23
6
2022
entrez:
25
4
2022
Statut:
ppublish
Résumé
After the coronavirus disease-19 (COVID-19) pandemic, the definition of health continuity, well-being, and well-dying is also evolving. This review is about the utilization of nuclear factor erythroid 2-related factor 2 (NRF2) for customized inner beauty products and customized cosmetics through Direct-To-Consumer (DTC) genetic testing in the non-face-to-face era that is evolving after the global pandemic. In May 2021, we proposed a narrative review as a new report and commentary. It was written with reference to keywords such as "Covid DTC Genetic Test," "Covid 4th industrial revolution," "Covid NRF2," and "Antioxidants." This study was performed by searching on PubMed, Google Scholar, Scopus, and ResearchGate. A total of 432 papers were retrieved, of which 40 were successfully included in this study. With the rapid transition to a non-face-to-face society after COVID-19, the concept of DTC was born, which allows consumers to receive genetic testing directly without visiting a medical institution. Based on the 4th industrial revolution, a convergence medical device is needed to secure the function as an NRF2 regulator of antioxidants in customized inner beauty products and customized cosmetics. Therefore, let us look at the fact that a fusion medical device based on the 4th industrial revolution has emerged in the global DTC genetic test market, which is still insufficient to summarize important research results. This study is expected to be an important data for the development of antioxidants as NRF2 regulators in customized inner beauty products and customized cosmetics. As mobile use increases in the future, additional research focusing on app development is needed, and various follow-up studies are also needed.
Sections du résumé
BACKGROUND
BACKGROUND
After the coronavirus disease-19 (COVID-19) pandemic, the definition of health continuity, well-being, and well-dying is also evolving.
OBJECTIVES
OBJECTIVE
This review is about the utilization of nuclear factor erythroid 2-related factor 2 (NRF2) for customized inner beauty products and customized cosmetics through Direct-To-Consumer (DTC) genetic testing in the non-face-to-face era that is evolving after the global pandemic.
METHODS
METHODS
In May 2021, we proposed a narrative review as a new report and commentary. It was written with reference to keywords such as "Covid DTC Genetic Test," "Covid 4th industrial revolution," "Covid NRF2," and "Antioxidants." This study was performed by searching on PubMed, Google Scholar, Scopus, and ResearchGate. A total of 432 papers were retrieved, of which 40 were successfully included in this study.
RESULTS
RESULTS
With the rapid transition to a non-face-to-face society after COVID-19, the concept of DTC was born, which allows consumers to receive genetic testing directly without visiting a medical institution. Based on the 4th industrial revolution, a convergence medical device is needed to secure the function as an NRF2 regulator of antioxidants in customized inner beauty products and customized cosmetics.
CONCLUSION
CONCLUSIONS
Therefore, let us look at the fact that a fusion medical device based on the 4th industrial revolution has emerged in the global DTC genetic test market, which is still insufficient to summarize important research results. This study is expected to be an important data for the development of antioxidants as NRF2 regulators in customized inner beauty products and customized cosmetics. As mobile use increases in the future, additional research focusing on app development is needed, and various follow-up studies are also needed.
Identifiants
pubmed: 35466548
doi: 10.1111/jocd.14467
pmc: PMC9115250
doi:
Substances chimiques
Antioxidants
0
Cosmetics
0
NF-E2-Related Factor 2
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2288-2297Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Cancer Lett. 2005 Jun 28;224(2):171-84
pubmed: 15914268
Psychiatr Serv. 2020 Aug 1;71(8):803-809
pubmed: 32362226
Planta Med. 2008 Oct;74(13):1526-39
pubmed: 18937164
Trends Pharmacol Sci. 2020 Sep;41(9):598-610
pubmed: 32711925
Int Arch Allergy Immunol. 2021;182(4):324-338
pubmed: 33567446
Mayo Clin Proc. 2018 Jan;93(1):113-120
pubmed: 29304915
Am J Psychiatry. 2014 Mar;171(3):360-8
pubmed: 24435025
Front Immunol. 2020 Oct 07;11:570122
pubmed: 33117359
Biochem Pharmacol. 2012 Nov 15;84(10):1351-8
pubmed: 22935448
J Genet Couns. 2021 Feb;30(1):329-334
pubmed: 32648332
J Med Internet Res. 2015 Dec 14;17(12):e279
pubmed: 26677835
Nat Commun. 2020 Oct 2;11(1):4938
pubmed: 33009401
JMIR Mhealth Uhealth. 2021 Apr 23;9(4):e25377
pubmed: 33890859
Methods Mol Biol. 2010;647:37-74
pubmed: 20694660
JMIR Mhealth Uhealth. 2020 Sep 16;8(9):e18339
pubmed: 32936078
J Genet Couns. 2021 Feb;30(1):191-197
pubmed: 32706156
Expert Rev Anti Infect Ther. 2020 Dec;18(12):1201-1211
pubmed: 32749914
Biomol Ther (Seoul). 2012 Mar;20(2):144-51
pubmed: 24116287
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621
pubmed: 33705239
J Cosmet Dermatol. 2021 Oct;20(10):3085-3092
pubmed: 34632697
BMC Health Serv Res. 2019 Nov 25;19(1):844
pubmed: 31760949
J Cosmet Dermatol. 2021 Jul;20(7):1975-1991
pubmed: 33834593
J Food Biochem. 2021 Jan;45(1):e13557
pubmed: 33171544
J Med Virol. 2020 Jun;92(6):556-563
pubmed: 32104907
J Cosmet Dermatol. 2022 Jun;21(6):2288-2297
pubmed: 35466548
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4049-54
pubmed: 22578462
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12475-80
pubmed: 11035812
Clin Transl Allergy. 2020 Dec 3;10(1):58
pubmed: 33292691
Oncogene. 1998 Dec 17;17(24):3145-56
pubmed: 9872330
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):89-97
pubmed: 29512889
Arch Biochem Biophys. 2019 Dec 15;678:108184
pubmed: 31733215
Free Radic Biol Med. 2004 May 15;36(10):1199-207
pubmed: 15110384
Can J Ophthalmol. 2020 Jun;55(3 Suppl 1):1
pubmed: 32340723
Pers Ubiquitous Comput. 2020 Sep 12;:1-9
pubmed: 32952494
Int Immunopharmacol. 2021 Jan;90:107247
pubmed: 33307513
FEBS J. 2020 Sep;287(17):3633-3650
pubmed: 32446285